NASDAQ:FMED Fidelity Disruptive Medicine ETF (FMED) Price, Holdings, & News $23.91 -0.03 (-0.13%) As of 09:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends About Fidelity Disruptive Medicine ETF (NASDAQ:FMED) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get FMED alerts:Sign Up Key Stats Today's Range$23.50▼$23.6850-Day Range$23.44▼$26.6152-Week Range$23.32▼$26.79Volume2,038 shsAverage Volume5,553 shsMarket Capitalization$50.21 millionAssets Under Management$50.26 millionDividend Yield0.46%Net Expense Ratio0.50%Aggregate RatingModerate Buy ETF OverviewThe Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.Read More… Remove Ads Fidelity Disruptive Medicine ETF ExpensesTypeFMEDTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.57%0.56%0.52%0.53%Other Expenses0.00%0.57%0.50%0.44%0.53%Total Expense0.50%0.72%0.72%0.67%0.71%Fee Waiver0.00%-0.72%-0.50%-0.31%-0.55%Net Expense0.50%0.60%0.63%0.61%0.60% Receive FMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fidelity Disruptive Medicine ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address FMED ETF News HeadlinesFidelity Disruptive Medicine ETF declares $0.112 dividendDecember 22, 2024 | seekingalpha.comSee More Headlines FMED ETF - Frequently Asked Questions How have FMED shares performed this year? Fidelity Disruptive Medicine ETF's stock was trading at $24.66 on January 1st, 2025. Since then, FMED shares have decreased by 3.0% and is now trading at $23.9090. View the best growth stocks for 2025 here. Who are Fidelity Disruptive Medicine ETF's major shareholders? Fidelity Disruptive Medicine ETF's top institutional shareholders include Jane Street Group LLC (3.14%). How do I buy shares of Fidelity Disruptive Medicine ETF? Shares of FMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerFidelity Fund NameFidelity Disruptive Medicine ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:FMED Inception Date6/12/2023 Fund ManagerNiamh Brodie-Machura, Camille Carlstrom, Tim Codrington,Charlie Hebard,Michael Kim, Christopher Lee,William Shanley WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings62 Fund Statistics Assets Under Management$49.98 million Average Daily Volume$0.00 Discount/Premium-0.08% Administrator, Advisor and Custodian AdministratorFidelity Management & Research Company LLC AdvisorFidelity Management & Research Company LLC CustodianState Street Bank and Trust Company DistributorFidelity Distributors Company LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest900 shs Miscellaneous Outstanding Shares2,100,000Beta0.94 Creation Fee$200.00 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report Top 10 FMED HoldingsBoston Scientific (NYSE:BSX)Holding Weight: 7.64%Fidelity Securities Lending Cash Central FundHolding Weight: 5.96%Intuitive Surgical (NASDAQ:ISRG)Holding Weight: 4.80%Insulet (NASDAQ:PODD)Holding Weight: 4.66%UnitedHealth Group (NYSE:UNH)Holding Weight: 3.85%argenx (NASDAQ:ARGX)Holding Weight: 3.55%Danaher (NYSE:DHR)Holding Weight: 3.39%Waystar (NASDAQ:WAY)Holding Weight: 3.34%Penumbra (NYSE:PEN)Holding Weight: 3.33%UCB SAHolding Weight: 2.89%Full Holdings Details This page (NASDAQ:FMED) was last updated on 3/14/2025 by MarketBeat.com Staff From Our PartnersNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredTrump Shock to change everything Is this Trump’s next major move? Millionaire trading expert Imre Gams has found a bill that directs the Uni...Centurion Publishing | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump's 100-Day Plan Triggers Global RetaliationIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredMarch 18th: Gold SHOCK?Starting March 18th, a major shift could send gold soaring — or crashing. Either way this shift goes... ...InvestorPlace | SponsoredSomething strange is happening in Virginia…In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
